BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu ZT, Chen TC, Lu XX, Cheng J, Xie HY, Zhou L, Zheng SS. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients. World J Gastroenterol 2015; 21(34): 10054-10056 [PMID: 26379412 DOI: 10.3748/wjg.v21.i34.10054]
URL: https://www.wjgnet.com/1007-9327/full/v21/i34/10054.htm
Number Citing Articles
1
Irena Míková, Magdaléna Neřoldová, Jaroslav A. Hubáček, Dana Dlouhá, Milan Jirsa, Eva Honsová, Eva Sticová, Věra Lánská, Julius Špičák, Pavel Trunečka. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver TransplantationTransplantation 2020; 104(3): 526 doi: 10.1097/TP.0000000000002876
2
Nader Salari, Niloufar Darvishi, Kamran Mansouri, Hooman Ghasemi, Melika Hosseinian-Far, Fateme Darvishi, Masoud Mohammadi. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysisBMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00789-4
3
O. V. Smirnova, D. V. Lagutinskaya. The role of polymorphisms of <I>PNPLA3</I>, <I>MBOAT7</I>, and <I>TM6SF2</I> in the development of non-alcoholic fatty liver disease in metabolic syndromeObesity and metabolism 2022; 19(2): 166 doi: 10.14341/omet12855
4
Ahad Eshraghian, Elham Moasser, Negar Azarpira, Mohammad Reza Fattahi, Saman Nikeghbalian, Seyed Ali Malek-Hosseini, Bita Geramizadeh. Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional studyBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02041-8
5
Guangrong Dai, Pengfei Liu, Xiaomei Li, Xiaoyan Zhou, Shuixiang He. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severityMedicine 2019; 98(7): e14324 doi: 10.1097/MD.0000000000014324
6
Alberto Savino, Alessandro Loglio, Flavia Neri, Stefania Camagni, Luisa Pasulo, Maria Grazia Lucà, Roberto Trevisan, Stefano Fagiuoli, Mauro Viganò. Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging IssueJournal of Clinical Medicine 2024; 13(13): 3871 doi: 10.3390/jcm13133871
7
Matthew Kappus, Manal Abdelmalek. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver TransplantationClinics in Liver Disease 2017; 21(2): 321 doi: 10.1016/j.cld.2016.12.006
8
Amal A. Mohamed, Rania Al Dweik, Reem A. Abdelghafour, Ahmed Ramadan, Abbas M. Abbas, Hussein H. Samir, Nashwa M. Muharram, Randa Ibrahim Ahmed Elshiha, Naglaa El-Salawy, Doaa Ghaith, Marwa K. Darwish, Soha M. Abd El Salam, Eman A. Sultan, Amina S. Soliman, Mohamed Ezz AL Arab, Ahmed Yosri Elamir, Ahmed Ali Mohamed, Al-Shaymaa A. Hassanin, Alaa Ali Mohamed Abouaggour, Wael Hafez, Mohamed M. Omran. Anthropometry, laboratory, and PNPLA3 polymorphisms in a novel model for early identification and evaluation of nonalcoholic fatty liver diseaseInformatics in Medicine Unlocked 2024; 48: 101513 doi: 10.1016/j.imu.2024.101513
9
Sanjaya K. Satapathy, Quynh T. Tran, Alexander J. Kovalic, Sai Vineela Bontha, Yu Jiang, Satish Kedia, Saradashri Karri, Vamsee Mupparaju, Pradeep S. B. Podila, Rajanshu Verma, Daniel Maluf, Valeria Mas, Satheesh Nair, James D. Eason, Dave Bridges, David E. Kleiner. Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver TransplantationClinical and Translational Gastroenterology 2021; 12(2): e00302 doi: 10.14309/ctg.0000000000000302
10
Pavel Trunečka, Irena Míková, Dana Dlouhá, Jaroslav A. Hubáček, Eva Honsová, Libor Kolesár, Věra Lánská, Soňa Fraňková, Jan Šperl, Milan Jirsa, Rudolf Poledne. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based studyDigestive and Liver Disease 2018; 50(5): 490 doi: 10.1016/j.dld.2017.12.030
11
Yan Xia, Chun-Xia Huang, Guang-Yi Li, Kai-Hua Chen, Li Han, Liang Tang, Huai-qing Luo, Mei-Hua Bao. Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibilityClinics and Research in Hepatology and Gastroenterology 2019; 43(5): 533 doi: 10.1016/j.clinre.2019.01.008
12
M. Shadab Siddiqui, Michael Charlton. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant ManagementGastroenterology 2016; 150(8): 1849 doi: 10.1053/j.gastro.2016.02.077
13
Hyeyoung Kim, Kwang‐Woong Lee, Kyoungbun Lee, Sooin Seo, Min‐Young Park, Sung Woo Ahn, Suk Kyun Hong, Kyung Chul Yoon, Hyo‐Sin Kim, YoungRok Choi, Hae Won Lee, Nam‐Joon Yi, Kyung‐Suk Suh. Effect of PNPLA3 I148M polymorphism on histologically proven non‐alcoholic fatty liver disease in liver transplant recipientsHepatology Research 2018; 48(3) doi: 10.1111/hepr.12940
14
Danielle Carter, Douglas T. Dieterich, Charissa Chang. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver TransplantationClinics in Liver Disease 2018; 22(1): 213 doi: 10.1016/j.cld.2017.08.015
15
Thomas G. Cotter, Michael Charlton. Nonalcoholic Steatohepatitis After Liver TransplantationLiver Transplantation 2020; 26(1): 141 doi: 10.1002/lt.25657
16
Natalie H. Bzowej. Nonalcoholic steatohepatitisCurrent Opinion in Organ Transplantation 2018; 23(2): 169 doi: 10.1097/MOT.0000000000000502
17
Rosa Lombardi, Giuseppina Pisano, Silvia Fargion, Anna Ludovica Fracanzani. Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitisExploration of Medicine 2021;  doi: 10.37349/emed.2021.00030
18
Zhengtao Liu, Jun Xu, Shuping Que, Lei Geng, Lin Zhou, Adil Mardinoglu, Shusen Zheng. Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver TransplantationJournal of Clinical and Translational Hepatology 2022; 10(2): 363 doi: 10.14218/JCTH.2021.00219
19
Zhengtao Liu, Wenchao Wang, Xiang Li, Junsheng Zhao, Hai Zhu, Shuping Que, Yong He, Jun Xu, Lin Zhou, Adil Mardinoglu, Shusen Zheng. Multi-omics network analysis on samples from sequential biopsies reveals vital role of proliferation arrest for Macrosteatosis related graft failure in rats after liver transplantationGenomics 2023; 115(6): 110748 doi: 10.1016/j.ygeno.2023.110748
20
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical ChallengesDigestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
21
Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, Amedeo Carraro, Christopher D. Byrne, Giovanni Targher. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantationNature Reviews Endocrinology 2022; 18(10): 638 doi: 10.1038/s41574-022-00711-5
22
Julia Kozlitina, Naomi M. Cohen, Drew Sturtevant, Jonathan C. Cohen, Cathi Murphey-Half, Jerome G. Saltarrelli, Peter Jindra, Medhat Askar, Christine S. Hwang, Parsia A. Vagefi, Chantale Lacelle, Helen H. Hobbs, Malcolm P. MacConmara. Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort studyeClinicalMedicine 2024; 67: 102350 doi: 10.1016/j.eclinm.2023.102350